Design
Review
Authors
Loading...
May accelerate genomic CV therapeutics; leaves open routine personalized medicine pending prospective validation.
Key points are not available for this paper at this time.
Sawhney et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: